One-drop blood test company Theranos, which was once worth $9 billion, reportedly plans to give out shares from its Founder Elizabeth Holmes' personal stake to investors who promise not to sue the company. Investors in Theranos' latest funding rounds could get two additional shares for each one they bought. Theranos is currently facing lawsuits questioning the accuracy of its tests.